Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTAMESA: Asenapine vs Olanzapine in Schizophrenia
NCT00212784Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2003
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in schizophrenia, schizoaffective disorder, sponsored by Organon & Co.. Started Sep 2003; status: completed.
02
Drugs
asenapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00212784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212784.